Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy. [electronic resource]
Producer: 20200417Description: 4274-4283 p. digitalISSN:- 1534-4681
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Neoadjuvant Therapy -- mortality
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm, Residual -- drug therapy
- Prognosis
- Prospective Studies
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Validation Study
There are no comments on this title.
Log in to your account to post a comment.